CervoMed Inc.
CRVONasdaqCIK 1053691HealthcareFiscal year ends Dec 31
Reports and events: 402 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:20 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-033943 |
| 2026-10-1416:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-032620 |
| 2026-10-1308:36 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032502 |
| 2026-10-0916:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-032445 |
| 2026-09-2817:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-031389 |
| 2026-09-1016:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-030073 |
| 2026-08-1016:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026771 |
| 2026-08-0716:27 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-026592 |
| 2026-08-0407:52 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-025509 |
| 2026-07-1416:21 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-023538 |
| 2026-07-0916:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-023200 |
| 2026-06-2216:13 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-021309 |
| 2026-06-2220:58 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-021208 |
| 2026-06-1807:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-021038 |
| 2026-06-1517:37 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001437749-26-020692 |
| 2026-06-1517:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-020672 |
| 2026-06-1007:40 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-020080 |
| 2026-06-0906:02 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-019909 |
| 2026-05-1816:58 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-017637 |
| 2026-05-1509:11 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-017236 |
| 2026-04-3009:26 ET | DEF 14A | Proxy statementPeriod 2026-06-08 | 0001437749-26-014032 |
| 2026-04-2216:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-013037 |
| 2026-04-0716:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-011597 |
| 2026-03-2316:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-009388 |
| 2026-03-1916:40 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-009081 |
| 2026-03-1716:31 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-008611 |
| 2026-03-1317:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-008259 |
| 2026-03-0416:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-006911 |
| 2026-02-1816:25 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-004555 |
| 2026-01-0816:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-000883 |
| 2025-12-0516:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-037025 |
| 2025-11-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034095 |
| 2025-11-0716:47 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-033879 |
| 2025-11-0407:08 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-032869 |
| 2025-10-2916:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-032184 |
| 2025-10-2216:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-031523 |
| 2025-10-0816:33 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-030719 |
| 2025-08-1108:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-025814 |
| 2025-08-0809:18 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-025570 |
| 2025-08-0516:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-024847 |
| 2025-07-2816:08 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-023646 |
| 2025-06-2517:10 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-021278 |
| 2025-05-1916:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-017613 |
| 2025-05-1216:29 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-016131 |
| 2025-05-1209:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-015966 |
| 2025-04-2916:26 ET | DEF 14A | Proxy statementPeriod 2025-06-23 | 0001437749-25-013543 |
| 2025-04-1812:32 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-012337 |
| 2025-04-0716:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-011178 |
| 2025-03-1816:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-008249 |
| 2025-03-1708:19 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-007829 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:21 ET. Listed shows no prices and gives no investment advice.